Lullimend Cream contains Luliconazole 1% w/w, a topical antifungal agent indicated for the treatment of superficial fungal infections of the skin, including dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole belongs to the imidazole class of antifungals and exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation allows for targeted application to affected areas, promoting rapid symptom relief such as itching, redness, and scaling. Lullimend Cream is typically applied once daily to the cleansed and dried affected skin for a duration recommended by a healthcare professional, usually ranging from one to two weeks depending on the infection type and severity. It is well tolerated with minimal systemic absorption, reducing the risk of systemic side effects. Common adverse reactions may include mild local irritation, burning sensation, or erythema at the application site, which generally resolve without discontinuation. Lullimend Cream should be used with caution in patients with known hypersensitivity to luliconazole or other imidazole antifungals. It is contraindicated in cases of extensive skin damage or open wounds. Proper adherence to treatment duration is essential to prevent recurrence and resistance.